Persistent fistula tracks in perianal Crohn's disease after long term infliximab treatment: Correlation with clinical outcome

被引：1
|
作者：
Van Assche, GA
Vanbeckevoort, D
Bielen, D
D'Haens, G
D'Hoore, A
Penninckx, F
Coremans, G
Rutgeerts, P
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80014-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [31] Clinical outcome of Crohn's disease treated with infliximab
    Arslan, S
    Kav, T
    Besisik, F
    Kaymakoglu, S
    Pinarbasi, B
    Tözün, N
    Hamzaoglu, HÖ
    Duman, D
    Ülker, A
    Parlak, E
    Palabiyikoglu, M
    Dökmeci, A
    HEPATO-GASTROENTEROLOGY, 2003, 50 (52) : 952 - 956
  • [32] Infliximab Treatment for Anal Fistula in Patients with Crohn's Disease
    Higashi, Daijiro
    Futami, Kitaro
    Egawa, Yuji
    Hirano, Kennji
    Tomiyasu, Takashige
    Ishibashi, Yukiko
    Simomura, Tamotsu
    Nii, Kaori
    Kuroki, Hirosuke
    Maekawa, Takafumi
    Ono, Yoichiro
    Matsui, Toshiyuki
    ANTICANCER RESEARCH, 2009, 29 (03) : 927 - 933
  • [33] Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab:: how long should patients be treated?
    Domènech, E
    Hinojosa, J
    Nos, P
    Garcia-Planella, E
    Cabré, E
    Bernal, I
    Gassull, MA
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (11-12) : 1107 - 1113
  • [34] Long-term Outcome of Maintenance Infliximab Therapy in Children with Crohn's Disease
    Hyoms, Jeffrey S.
    Lerer, Trudy
    Griffiths, Anne
    Pfefferkorn, Marian
    Kugathasan, Subra
    Evans, Jonathan
    Otley, Anthony
    Carvalho, Ryan
    Mack, David
    Bousvaros, Athos
    Rosh, Joel
    Mamula, Petar
    Kay, Marsha
    Crandall, Wallace
    Oliva-Hemker, Maria
    Keljo, David
    LeLeiko, Neal
    Markowitz, James
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (06) : 816 - 822
  • [35] LONG-TERM OUTCOME OF ADVANCEMENT FLAP REPAIR OF ANORECTAL FISTULA IN CROHN'S DISEASE IN THE ERA OF INFLIXIMAB: PREDICTORS OF SUCCESS
    Khaitov, S.
    Karas, J.
    Gorfine, S.
    Chessin, D.
    DISEASES OF THE COLON & RECTUM, 2009, 52 (04) : 829 - 829
  • [36] Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
    Maser, Elana A.
    Villela, Renata
    Silverberg, Mark S.
    Greenberg, Gordon R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (10) : 1248 - 1254
  • [37] Long-term infliximab treatment in a patient with fistualizing Crohn's disease
    Wisniewska-Jarosinska, Maria
    Wichan, Pawel
    Chojnacki, Jan
    PRZEGLAD GASTROENTEROLOGICZNY, 2009, 4 (05): : 277 - 281
  • [38] Long term treatment with infliximab in non-fistulising Crohn's disease
    Vermeire, Severine
    Van Assche, G.
    Rutgeerts, P.
    ACTA ENDOSCOPICA, 2007, 37 (03) : 271 - 283
  • [39] Long- Term Outcome of Treatment With Infliximab in Paediatric Crohn's Disease: a Population-Based Study
    Crombe, Valerie
    Salleron, Julia
    Savoye, Guillaume
    Dupas, Jean-Louis
    Vernier-Massouille, Gwenola
    Lerebours, Eric
    Turck, Dominique
    Cortot, Antoine
    Gower-Rousseau, Corinne
    Lemann, Marc
    Colombel, Jean-Frederic
    Duhamel, Alain
    GASTROENTEROLOGY, 2010, 138 (05) : S300 - S300
  • [40] Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease
    Davidov, Yana
    Ungar, Bella
    Bar-Yoseph, Haggai
    Carter, Dan
    Haj-Natour, Ola
    Yavzori, Miri
    Chowers, Yehuda
    Eliakim, Rami
    Ben-Horin, Shomron
    Kopylov, Uri
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (05): : 549 - 555
12345